Pfizer India updates: news & description

Presence

Pfizer India develops, manufactures, and markets pharmaceutical products in India. Its main offerings include prescription medicines and vaccines for hospitals, clinics, pharmacies, and patients.

Pfizer India products and services overview:

Prescription medicines
Vaccines
Hospital products
Primary care drugs
Specialty medicines

Revenue: ~$300 million

Employees: 2,000

Headquarters: Mumbai, India

Pfizer India is owned by Pfizer.

Pfizer is one of the...

Pfizer is a company listed under the stock ticker PFE (US).

Pfizer has a direct presence in 39 countries.

Pfizer has 49 subsidiaries including Metsera, Pfizer ANZ and Pfizer Asia.

They are in:

Pharmaceuticals88%
Biotechnology12%

Acquisition, funding and merger involving Pfizer.

Pfizer has acquired Metsera (posted on November 14 2025).
Pfizer has announced the acquisition of Metsera (posted on September 24 2025).

Executives

View the org chart displaying its 14 main executives

Most searched biographies at Pfizer India

Popular executive movements at Pfizer India

Aditi Mehta, Director, Vaccines & Oncology Category, will leave the company on Jan. 2, 2026 (posted on December 25 2025).
Prachi Jha, Country Brand Manager, has left the company (posted on October 20 2025).

Popular executive movements at Pfizer

Andrew Baum, who is Executive Vice President and Chief Strategy & Innovation Officer will soon leave the company (posted on April 22 2026).
David McGettigan, Senior Vice President, Global Business Services, has left the company (posted on April 20 2026).
Jean-Marie Geoffroy, Vice President, Sterile Injectables Design, has left the company (posted on April 20 2026).

Click here to view some more movements at Pfizer

Create your alert
to follow the executive moves at Pfizer India.